Estimates of Intracellular Dopamine in Parkinson’s Disease: A Systematic Review and Meta-Analysis

Author:

Sackner-Bernstein Jonathan1

Affiliation:

1. Principal, ExVivos, LLC, Hastings-on-Hudson, NY, USA

Abstract

Background: The hallmark of Parkinson’s disease is depletion of dopamine in the basal ganglia. Models of Parkinson’s disease include dopamine as a contributor to disease progression. However, intraneuronal levels of dopamine have not been reported. Objective: Meta-analytic methods were utilized to determine intracellular dopamine levels in Parkinson’s disease. Methods: A systematic review of the literature and frequentist meta-analyses were performed. Dopamine levels were scaled for cell and axon numbers as well as VMAT2 protein levels. Results: Reduced tissue dopamine, dopaminergic cell bodies and VMAT2 protein were confirmed. The ratio of Parkinson’s to normal brain intracellular dopamine scaled for either cell or axon number, each with VMAT2 level in the caudate ranged from 1.49 to 1.87 (p = 0.51 and p = 0.12, respectively) and in the putamen from 0.75 to 4.61 (p = 0.40 and 0.001, respectively). Conclusion: Free, intracellular dopamine levels are not reduced in Parkinson’s disease compared to normals to a similar degree as are total tissue concentrations, supporting the relevance of modulating VMAT2, neuromelanin and/or dopamine synthesis as rational neuroprotective strategies.

Publisher

IOS Press

Subject

Cellular and Molecular Neuroscience,Neurology (clinical)

Reference40 articles.

1. Parkinsonism and related disorders. The 200-year journey of Parkinson disease: Reflecting on the past and looking towards the future;Fahn;Parkinsonism Relat Disord,2017

2. Aromatic amino acids and modification of parkinsonism;Cotzias;N Engl J Med,1967

3. Initiating dopaminergic treatment in Parkinson’s disease;Lang;Lancet,2014

4. Overexpression of vesicular monoamine transporter-2 may block neurotoxic metabolites from cytosolic dopamine: A potential neuroprotective therapy for Parkinson’s disease;Segura-Aguilar;Clin Pharmacol Trans Med,2020

5. VMAT2 and Parkinson’s disease: Harnessing the dopamine vesicle;Lohr;Expert Rev Neurother,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3